Palatin Technologies

+$0.024 (+5.26%) Today
-$0.02 (-4.17%) As of 11:30 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTN and other ETFs, options, and stocks.

About PTN

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, a peptide melanocortin receptor 4 agonist for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD).

CEO
Carl Spana
Employees
20
Headquarters
Cranbury, New Jersey
Founded
1986

PTN Key Statistics

Market Cap
112.82M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.14M
High Today
$0.47
Low Today
$0.4502
Open Price
$0.4652
Volume
1.28M
52 Week High
$1.30
52 Week Low
$0.375

PTN Earnings

-$0.04
-$0.03
-$0.01
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Sep 23, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure